Erlotinib Completed Phase 2 Trials for Stage II Pancreatic Cancer / Stage IV Pancreatic Cancer / Adenocarcinoma of the Pancreas / Recurrent Pancreatic Cancer / Stage III Pancreatic Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01222689Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
NCT00091026Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer
NCT01389440Efficacy and Safety of a Neoadjuvant Treatment in Pancreatic Cancer